MARKET

BNTC

BNTC

Benitec
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.6400
-0.0100
-1.54%
Closed 16:00 11/14 EST
OPEN
0.6500
PREV CLOSE
0.6500
HIGH
0.6500
LOW
0.6200
VOLUME
14.68K
TURNOVER
--
52 WEEK HIGH
2.650
52 WEEK LOW
0.5000
MARKET CAP
8.22M
P/E (TTM)
2.888
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BNTC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

BNTC News

  • Appendix 4C: Quarterly Cash Flow Report
  • PR Newswire.10/31 13:30
  • The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch
  • Benzinga.10/16 11:06
  • 58 Biggest Movers From Yesterday
  • Benzinga.10/01 09:56
  • 31 Stocks Moving In Monday's Mid-Day Session
  • Benzinga.09/30 17:13

More

Industry

Biotechnology & Medical Research
-0.05%
Pharmaceuticals & Medical Research
-0.27%

Hot Stocks

Name
Price
%Change

About BNTC

Benitec Biopharma Limited is a biotechnology company. The Company is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property (IP); development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. Its In-house product candidates include TT-034, BB-HB-331, BB-AMD-211 and ddRNAi therapeutic. It is focused on commercialization by licensing and partnering of patents and licenses in biotechnology, in functional genomics, with applications in biomedical research and human therapeutics. It has a pipeline of in-house and partnered therapeutic programs based on its patented gene-silencing technology, deoxyribonucleic acid (DNA)-directed ribonucleic acid interference (ddRNAi). The Company is engaged in developing treatments for chronic human conditions, such as hepatitis B, wet age-related macular degeneration (AMD), and oculopharyngeal muscular dystrophy (OPMD) based on this technology.
More

Webull offers Benitec Biopharma Ltd (BNTC) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.